NCT00161811View on ClinicalTrials.gov

Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

1,400

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

July 31, 2005

Conditions

Influenza

Interventions

BIOLOGICAL

Vero Cell-derived Influenza Vaccine

BIOLOGICAL

Egg cell-derived Influenza Vaccine

Trial Locations (4)

1090

Vienna General Hospital (AKH), Department of Clinical Pharmacology, Vienna

16761

Neuendorfstr. 20, Henningsdorf

55116

Münstererstr. 1a, Mainz

D-55101

Mainz University Children´s Clinic, Mainz

All Listed Sponsors

lead

Alachua Government Services, Inc.

INDUSTRY

NCT00161811 - Comparison of the Safety and Immune Response of Three Different Lots of an Influenza Vaccine Made by a New Manufacturing Process With a Vaccine Made by the Traditional Manufacturing Process for Season 2004/2005 | Biotech Hunter | Biotech Hunter